Tsukasa Hasegawa Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2023	Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02).
3/2021	Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer.
9/2020	Association Between the Efficacy of Pembrolizumab and Low STK11/LKB1 Expression in High-PD-L1-expressing Non-small-cell Lung Cancer.
3/2020	Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors.
1/2020	Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment.
1/2020	Poor efficacy of anti-programmed cell death-1/ligand 1 monotherapy for non-small cell lung cancer patients with active brain metastases.
1/2020	Association between continuous decrease of plasma VEGF-A levels and the efficacy of chemotherapy in combination with anti-programmed cell death 1 antibody in non-small cell lung cancer patients.
1/2020	Efficacy of anti-PD-1 therapy for recurrence after chemoradiotherapy in locally advanced NSC LC.
12/2019	Association of High Neutrophil-to-Lymphocyte Ratio With Poor Outcomes of Pembrolizumab Therapy in High-PD-L1-expressing Non-small Cell Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsukasa Hasegawa Research Topics

Disease

9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 12/2019
4	Neoplasms (Cancer) 09/2020 - 12/2019
2	Prostatic Neoplasms (Prostate Cancer) 06/2024 - 01/2020
2	Pneumonia (Pneumonitis) 06/2024 - 01/2023
1	Reversed halo sign 06/2024
1	COVID-19 01/2023
1	Disease Progression 01/2023
1	Ankylosing Spondylitis 08/2021
1	Allergic Bronchopulmonary Aspergillosis 08/2021
1	Cough 08/2021
1	Respiratory Sounds (Crackle) 08/2021
1	Necrosis 08/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2020
1	Inflammation (Inflammations) 12/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Cryptogenic Organizing Pneumonia 01/2019
1	Bronchiectasis 01/2019
1	Neutropenia 11/2018
1	Inappropriate ADH Syndrome (SIADH) 01/2017
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2017
1	Hyponatremia 01/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2015
1	Alzheimer Disease (Alzheimer's Disease) 03/2004

Drug/Important Bio-Agent (IBA)

4	B7-H1 AntigenIBA 03/2020 - 01/2020
2	pembrolizumabIBA 09/2020 - 12/2019
2	LigandsIBA 09/2020 - 01/2020
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2015 - 03/2004
1	darolutamideIBA 06/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2024
1	durvalumabIBA 01/2023
1	Ferritins (Ferritin)IBA 01/2023
1	Carbon MonoxideIBA 01/2023
1	Adalimumab (Humira)FDA Link 08/2021
1	Bevacizumab (Avastin)FDA Link 03/2021
1	Indicators and Reagents (Reagents)IBA 12/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	isoindigotinIBA 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	AcidsIBA 01/2020
1	AntibodiesIBA 01/2020
1	AntigensIBA 01/2020
1	PolymersIBA 01/2020
1	Molecular Probes (Molecular Probe)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	SteroidsIBA 01/2019
1	Inosine TriphosphataseIBA 11/2018
1	Azathioprine (Imuran)FDA LinkGeneric 11/2018
1	Vasopressins (Vasopressin)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 12/2015
1	Glycogen Synthase Kinase 3 betaIBA 03/2004
1	tau-protein kinaseIBA 03/2004

Therapy/Procedure

3	Therapeutics 01/2023 - 12/2019
2	Chemoradiotherapy 01/2023 - 01/2020
2	Drug Therapy (Chemotherapy) 03/2021 - 01/2020
1	Humidifiers 06/2024
1	Intravenous Administration 01/2020
1	Traction 01/2019